NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|692428049|ref|WP_032138493|]
View 

aminopeptidase N [Coxiella burnetii]

Protein Classification

aminopeptidase N( domain architecture ID 11494252)

aminopeptidase N catalyzes the cleavage of amino acids from the N-terminus of proteins or peptides

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
pepN_proteo TIGR02414
aminopeptidase N, Escherichia coli type; The M1 family of zinc metallopeptidases contains a ...
13-877 0e+00

aminopeptidase N, Escherichia coli type; The M1 family of zinc metallopeptidases contains a number of distinct, well-separated clades of proteins with aminopeptidase activity. Several are designated aminopeptidase N, EC 3.4.11.2, after the Escherichia coli enzyme, suggesting a similar activity profile (see SP|P04825 for a description of catalytic activity). This family consists of all aminopeptidases closely related to E. coli PepN and presumed to have similar (not identical) function. Nearly all are found in Proteobacteria, but members are found also in Cyanobacteria, plants, and apicomplexan parasites. This family differs greatly in sequence from the family of aminopeptidases typified by Streptomyces lividans PepN (TIGR02412), from the membrane bound aminopeptidase N family in animals, etc. [Protein fate, Degradation of proteins, peptides, and glycopeptides]


:

Pssm-ID: 274122 [Multi-domain]  Cd Length: 863  Bit Score: 1560.38  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   13 DYRPSDFLIDTVHLYFDLHEEETHVKTILNLQRNPEGNAtAPLALTGEAMTLKKVALDGQTLASSDYTLDASSLTIANVP 92
Cdd:TIGR02414   1 DYKPPPFLIEKTHLDFDLHEEETVVRARLTVRRNPDGNG-APLVLDGEELKLLSIAIDGKPLAAGDYQLDDETLTIASVP 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   93 NEFTLETEVVIKPQENTQLMGLYKSRGNFCTQCESHGFRRITYFLDRPDVMARYTTTIIADKNKYPFLLSNGNLIETKIL 172
Cdd:TIGR02414  80 ESFTLEIETEIHPEENTSLEGLYKSGGNFCTQCEAEGFRRITYFPDRPDVMSRYTVTITADKKKYPVLLSNGNKIASGEL 159
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  173 SDNRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVTQSGREIALRLYLEKGFKDQGPFSLAALKKAMRWDEKRFGREYDL 252
Cdd:TIGR02414 160 PDGRHWAEWEDPFPKPSYLFALVAGDLDVLEDTFTTKSGREVALRVYVEEGNKDKCDHAMESLKKAMKWDEEVFGLEYDL 239
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  253 DIYMIVAVSDFNMGAMENKGLNIFNTKYILANPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQITLKEGLTVFRE 332
Cdd:TIGR02414 240 DIFMIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFRD 319
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  333 QLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPRSYIEVNNFYTTTVYNKGSEVIRMVQTLLGEALFRKAMDLY 412
Cdd:TIGR02414 320 QEFSADMTSRAVKRIEDVRLLRAHQFPEDAGPMAHPVRPESYVEINNFYTATVYEKGAEVIRMLHTLLGEEGFRKGMDLY 399
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  413 FSRYDGQAVTTEDFIQAMEDASGKNLEQFKRWYDQAGTPVLDVNSEYNANDKTLTLTVKQSCPPTPGQSEKLPFHLPLTL 492
Cdd:TIGR02414 400 FSRHDGQAVTCEDFVAAMEDASGRDLNQFRRWYSQAGTPVLEVKENYDAAKKTYTLTVRQSTPPTPGQTEKKPLHIPIAV 479
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  493 GFVGPECQDMPTQLAGEkkaIPGTRVLEIKDAETEFKFVNVNHKPTLSLLRGFSAPVRLNYPYSDEELVWLFQCDSDPFA 572
Cdd:TIGR02414 480 GLLGPNGRKLMLSLDGE---RDTTRVLELTEAEQTFVFEGIAEKPVPSLLRGFSAPVNLEYPYSDEDLLLLLAHDSDPFN 556
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  573 RYEAGQIFAQRLIFKLIDDSYQGKPLKIDERFIDAHRKIIAGPHRDHWYEADLLQLPNINYLMQLMKKMDVEALHTIRQF 652
Cdd:TIGR02414 557 RWEAGQRLARRVILANIARAQGGEELPVDPAFIDALGKLLNDPHLDAAFKALLLALPSEAYLAELMENIDPDALHAAREF 636
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  653 VKKALSNALVDDLKIQYEHHQLPL-YEYTPADIGKRKLKNICLAYLTESDDTQFRQVAYQQFKKSDNMTDTVGALSALLN 731
Cdd:TIGR02414 637 LRAAIARQLADDLLRLYDALQENGpYSVDPAAAGRRALRNACLSYLSAADDAEIRNLALEQFKSADNMTDRLAALSALVH 716
                         730       740       750       760       770       780       790       800
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  732 HDCKERHQALDEFYQQWKDQPLVVNKWLMLHASSTLPSTLEAVRKLTKHPAFDVKNPNNVYSLLGTFG-ANAVCFHEGSG 810
Cdd:TIGR02414 717 FESDFRERALAAFYQKWKDDPLVMDKWFALQATSPRPDTLERVKALLQHPAFDLKNPNRVRALIGAFAnNNLVRFHDISG 796
                         810       820       830       840       850       860
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 692428049  811 EGYRLIADYVLAIDPANPQVAARVLQPLTRWQMMDKKRQELMKAELNRIAKAERLSSDVYEIVTKSL 877
Cdd:TIGR02414 797 SGYRFLADQIIAIDRFNPQVAARLLEPLTRWRKLDPKRQELMKAALERIAAEENLSKDVREVVSKAL 863
 
Name Accession Description Interval E-value
pepN_proteo TIGR02414
aminopeptidase N, Escherichia coli type; The M1 family of zinc metallopeptidases contains a ...
13-877 0e+00

aminopeptidase N, Escherichia coli type; The M1 family of zinc metallopeptidases contains a number of distinct, well-separated clades of proteins with aminopeptidase activity. Several are designated aminopeptidase N, EC 3.4.11.2, after the Escherichia coli enzyme, suggesting a similar activity profile (see SP|P04825 for a description of catalytic activity). This family consists of all aminopeptidases closely related to E. coli PepN and presumed to have similar (not identical) function. Nearly all are found in Proteobacteria, but members are found also in Cyanobacteria, plants, and apicomplexan parasites. This family differs greatly in sequence from the family of aminopeptidases typified by Streptomyces lividans PepN (TIGR02412), from the membrane bound aminopeptidase N family in animals, etc. [Protein fate, Degradation of proteins, peptides, and glycopeptides]


Pssm-ID: 274122 [Multi-domain]  Cd Length: 863  Bit Score: 1560.38  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   13 DYRPSDFLIDTVHLYFDLHEEETHVKTILNLQRNPEGNAtAPLALTGEAMTLKKVALDGQTLASSDYTLDASSLTIANVP 92
Cdd:TIGR02414   1 DYKPPPFLIEKTHLDFDLHEEETVVRARLTVRRNPDGNG-APLVLDGEELKLLSIAIDGKPLAAGDYQLDDETLTIASVP 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   93 NEFTLETEVVIKPQENTQLMGLYKSRGNFCTQCESHGFRRITYFLDRPDVMARYTTTIIADKNKYPFLLSNGNLIETKIL 172
Cdd:TIGR02414  80 ESFTLEIETEIHPEENTSLEGLYKSGGNFCTQCEAEGFRRITYFPDRPDVMSRYTVTITADKKKYPVLLSNGNKIASGEL 159
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  173 SDNRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVTQSGREIALRLYLEKGFKDQGPFSLAALKKAMRWDEKRFGREYDL 252
Cdd:TIGR02414 160 PDGRHWAEWEDPFPKPSYLFALVAGDLDVLEDTFTTKSGREVALRVYVEEGNKDKCDHAMESLKKAMKWDEEVFGLEYDL 239
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  253 DIYMIVAVSDFNMGAMENKGLNIFNTKYILANPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQITLKEGLTVFRE 332
Cdd:TIGR02414 240 DIFMIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFRD 319
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  333 QLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPRSYIEVNNFYTTTVYNKGSEVIRMVQTLLGEALFRKAMDLY 412
Cdd:TIGR02414 320 QEFSADMTSRAVKRIEDVRLLRAHQFPEDAGPMAHPVRPESYVEINNFYTATVYEKGAEVIRMLHTLLGEEGFRKGMDLY 399
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  413 FSRYDGQAVTTEDFIQAMEDASGKNLEQFKRWYDQAGTPVLDVNSEYNANDKTLTLTVKQSCPPTPGQSEKLPFHLPLTL 492
Cdd:TIGR02414 400 FSRHDGQAVTCEDFVAAMEDASGRDLNQFRRWYSQAGTPVLEVKENYDAAKKTYTLTVRQSTPPTPGQTEKKPLHIPIAV 479
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  493 GFVGPECQDMPTQLAGEkkaIPGTRVLEIKDAETEFKFVNVNHKPTLSLLRGFSAPVRLNYPYSDEELVWLFQCDSDPFA 572
Cdd:TIGR02414 480 GLLGPNGRKLMLSLDGE---RDTTRVLELTEAEQTFVFEGIAEKPVPSLLRGFSAPVNLEYPYSDEDLLLLLAHDSDPFN 556
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  573 RYEAGQIFAQRLIFKLIDDSYQGKPLKIDERFIDAHRKIIAGPHRDHWYEADLLQLPNINYLMQLMKKMDVEALHTIRQF 652
Cdd:TIGR02414 557 RWEAGQRLARRVILANIARAQGGEELPVDPAFIDALGKLLNDPHLDAAFKALLLALPSEAYLAELMENIDPDALHAAREF 636
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  653 VKKALSNALVDDLKIQYEHHQLPL-YEYTPADIGKRKLKNICLAYLTESDDTQFRQVAYQQFKKSDNMTDTVGALSALLN 731
Cdd:TIGR02414 637 LRAAIARQLADDLLRLYDALQENGpYSVDPAAAGRRALRNACLSYLSAADDAEIRNLALEQFKSADNMTDRLAALSALVH 716
                         730       740       750       760       770       780       790       800
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  732 HDCKERHQALDEFYQQWKDQPLVVNKWLMLHASSTLPSTLEAVRKLTKHPAFDVKNPNNVYSLLGTFG-ANAVCFHEGSG 810
Cdd:TIGR02414 717 FESDFRERALAAFYQKWKDDPLVMDKWFALQATSPRPDTLERVKALLQHPAFDLKNPNRVRALIGAFAnNNLVRFHDISG 796
                         810       820       830       840       850       860
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 692428049  811 EGYRLIADYVLAIDPANPQVAARVLQPLTRWQMMDKKRQELMKAELNRIAKAERLSSDVYEIVTKSL 877
Cdd:TIGR02414 797 SGYRFLADQIIAIDRFNPQVAARLLEPLTRWRKLDPKRQELMKAALERIAAEENLSKDVREVVSKAL 863
pepN PRK14015
aminopeptidase N; Provisional
1-877 0e+00

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 1555.10  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   1 MSNQKPRTVYLKDYRPSDFLIDTVHLYFDLHEEETHVKTILNLQRNPEGNATAPLALTGEAMTLKKVALDGQTLASSDYT 80
Cdd:PRK14015   1 MRTQQPQAIYLKDYRPPDYLIDTVDLDFDLDPDKTRVTARLQVRRNPDAAHSAPLVLDGEDLELLSLALDGQPLAPSAYE 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  81 LDASSLTIANVPNEFTLETEVVIKPQENTQLMGLYKSRGNFCTQCESHGFRRITYFLDRPDVMARYTTTIIADKNKYPFL 160
Cdd:PRK14015  81 LDEEGLTIENLPDRFTLEIETEIDPEANTALEGLYRSGGMFCTQCEAEGFRRITYFLDRPDVLARYTVRIEADKAKYPVL 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 161 LSNGNLIETKILSDNRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVTQSGREIALRLYLEKGFKDQGPFSLAALKKAMR 240
Cdd:PRK14015 161 LSNGNLVESGELPDGRHWATWEDPFPKPSYLFALVAGDLDVLEDTFTTRSGREVALEIYVEPGNLDKCDHAMDSLKKSMK 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 241 WDEKRFGREYDLDIYMIVAVSDFNMGAMENKGLNIFNTKYILANPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQ 320
Cdd:PRK14015 241 WDEERFGLEYDLDIFMIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQ 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 321 ITLKEGLTVFREQLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPRSYIEVNNFYTTTVYNKGSEVIRMVQTLL 400
Cdd:PRK14015 321 LSLKEGLTVFRDQEFSADLGSRAVKRIEDVRVLRAAQFAEDAGPMAHPVRPDSYIEINNFYTATVYEKGAEVIRMLHTLL 400
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 401 GEALFRKAMDLYFSRYDGQAVTTEDFIQAMEDASGKNLEQFKRWYDQAGTPVLDVNSEYNANDKTLTLTVKQSCPPTPGQ 480
Cdd:PRK14015 401 GEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASGRDLSQFRRWYSQAGTPRVTVSDEYDAAAGTYTLTLSQSTPPTPGQ 480
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 481 SEKLPFHLPLTLGFVGPECQDMPTQLAGEkkaiPGTRVLEIKDAETEFKFVNVNHKPTLSLLRGFSAPVRLNYPYSDEEL 560
Cdd:PRK14015 481 PEKQPLHIPVAIGLLDPDGKELPLQLEGE----PVERVLELTEAEQTFTFENVAERPVPSLLRGFSAPVKLEYDYSDEDL 556
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 561 VWLFQCDSDPFARYEAGQIFAQRLIFKLIDDsyQGKPLKIDERFIDAHRKIIAGPHRDHWYEADLLQLPNINYLMQLMKK 640
Cdd:PRK14015 557 LFLMAHDSDPFNRWEAGQRLATRLLLANVAR--HGQPLSLDEALIDAFRAVLLDESLDPAFAAELLTLPSEAELAEQMEV 634
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 641 MDVEALHTIRQFVKKALSNALVDDLKIQYEHHQLP-LYEYTPADIGKRKLKNICLAYLTESDDTQFRQVAYQQFKKSDNM 719
Cdd:PRK14015 635 IDPDAIHAAREALRRALATALKDELLALYEALQTDgPYSPDAEAAGRRALRNVCLSYLAAADDEEAAELAEAQFDQADNM 714
                        730       740       750       760       770       780       790       800
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 720 TDTVGALSALLNHDCKERHQALDEFYQQWKDQPLVVNKWLMLHASSTLPSTLEAVRKLTKHPAFDVKNPNNVYSLLGTF- 798
Cdd:PRK14015 715 TDRLAALSALVNADLPERDEALADFYDRWKDDPLVMDKWFALQATSPAPDTLERVRALMQHPAFDLKNPNRVRSLIGAFa 794
                        810       820       830       840       850       860       870
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 692428049 799 GANAVCFHEGSGEGYRLIADYVLAIDPANPQVAARVLQPLTRWQMMDKKRQELMKAELNRIAKAERLSSDVYEIVTKSL 877
Cdd:PRK14015 795 AANPAGFHAADGSGYRFLADQILALDKINPQVAARLATPLIRWRRYDPKRQALMRAALERIAALPNLSKDVREIVSKAL 873
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
13-445 0e+00

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 861.44  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  13 DYRPSDFLIDTVHLYFDLHEEETHVKTILNLQRNPEGNATAPLALTGEAMTLKKVALDGQTLASSDYTLDASSLTIANVP 92
Cdd:cd09600    1 DYKPPDFLIDHVDLDFDLDDDETIVTSRLRVRRNPDSGEGAPLVLDGEDLELLSVKIDGKPLSPSDYTLDEEGLTIKNVP 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  93 NEFTLETEVVIKPQENTQLMGLYKSRGNFCTQCESHGFRRITYFLDRPDVMARYTTTIIADKNKYPFLLSNGNLIETKIL 172
Cdd:cd09600   81 DRFVLEIEVRINPAANTSLEGLYKSGGILCTQCEAEGFRRITYFPDRPDVMSKFTVTIEADKEKYPVLLSNGNLIEEGEL 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 173 SDNRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVTQSGREIALRLYLEKGFKDQGPFSLAALKKAMRWDEKRFGREYDL 252
Cdd:cd09600  161 PNGRHFAVWEDPFPKPSYLFALVAGDLGSVEDTFTTKSGRKVKLRIYVEPGNEDKCHHAMESLKKAMKWDEERFGLEYDL 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 253 DIYMIVAVSDFNMGAMENKGLNIFNTKYILANPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQITLKEGLTVFRE 332
Cdd:cd09600  241 DLFNIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFRD 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 333 QLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPRSYIEVNNFYTTTVYNKGSEVIRMVQTLLGEALFRKAMDLY 412
Cdd:cd09600  321 QEFSADMNSRAVKRIEDVRRLRSAQFPEDAGPMAHPIRPDSYIEINNFYTVTVYEKGAEVIRMLHTLLGEEGFRKGMDLY 400
                        410       420       430
                 ....*....|....*....|....*....|...
gi 692428049 413 FSRYDGQAVTTEDFIQAMEDASGKNLEQFKRWY 445
Cdd:cd09600  401 FERHDGQAVTCEDFVAAMEDASGRDLSQFKRWY 433
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
6-590 0e+00

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 551.17  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   6 PRTVYLKDYRPSDFLIDTVHLYFDLHEEETHVKTILNLQRNPEGNATAPLALTGEAMTLKKVALDGQTLassDYTLDASS 85
Cdd:COG0308    2 KRLTRLEAYRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEAPLDSLVLDLKGLEVTSVTVDGKPL---DFTRDGER 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  86 LTIAN----VPNE-FTLETEVVIKPQEntQLMGLYKS------RGNFCTQCESHGFRRitYFL--DRPDVMARYTTTIIA 152
Cdd:COG0308   79 LTITLpkplAPGEtFTLEIEYSGKPSN--GGEGLYRSgdppdgPPYLYTQCEPEGARR--WFPcfDHPDDKATFTLTVTV 154
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 153 DKnkYPFLLSNGNLIETKILSDNRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVtqSGreIALRLYLEKGFKDQGPFSL 232
Cdd:COG0308  155 PA--GWVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFA--SG--VPLRVYVRPGLADKAKEAF 228
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 233 AALKKAMRWDEKRFGREYDLDIYMIVAVSDFNMGAMENKGLNIFNTKYIlaNPQSATDDNYVAIESVIGHEYFHNWSGNR 312
Cdd:COG0308  229 ESTKRMLDFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVL--ADETATDADYERRESVIAHELAHQWFGNL 306
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 313 VTCRDWFQITLKEGLTVFREQLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPRSYIEVNNFYTTTVYNKGSEV 392
Cdd:COG0308  307 VTCADWDDLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSYAFAEDAGPNAHPIRPDDYPEIENFFDGIVYEKGALV 386
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 393 IRMVQTLLGEALFRKAMDLYFSRYDGQAVTTEDFIQAMEDASGKNL-EQFKRWYDQAGTPVLDVNSEYNANDKTlTLTVK 471
Cdd:COG0308  387 LHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLsAFFDQWLYQAGLPTLEVEYEYDADGKV-TLTLR 465
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 472 QScpptpgQSEKLPFHLPLTLGFVGPEcqdmptqlagekkaIPGTRVLeIKDAETEFKfvnvnHKPTLSLLrgfsapVRL 551
Cdd:COG0308  466 QT------PPRPHPFHIPLEVGLLGGK--------------LTARTVL-LDGEQTELV-----AKPDPVLL------LRL 513
                        570       580       590
                 ....*....|....*....|....*....|....*....
gi 692428049 552 nypysDEELVWLFQCDSDPFARYEAGQIFAQRLIFKLID 590
Cdd:COG0308  514 -----DDELAFLLAHDSDPFNRWEALQALWRDGEADYLD 547
DUF3458_C pfam17432
Domain of unknown function (DUF3458_C) ARM repeats; This presumed domain is functionally ...
557-877 1.33e-144

Domain of unknown function (DUF3458_C) ARM repeats; This presumed domain is functionally uncharacterized. This domain is found in bacteria, archaea and eukaryotes.


Pssm-ID: 465424 [Multi-domain]  Cd Length: 324  Bit Score: 430.40  E-value: 1.33e-144
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  557 DEELVWLFQCDSDPFARYEAGQIFAQRLIFKLIDDSYQGKPLKIDERFIDAHRKIIAGPHRDHWYEADLLQLPNINYLMQ 636
Cdd:pfam17432   1 DEDLAFLLAHDSDPFNRWEAGQTLALRLLLALVAALQAGEPLALDAAFIDAFRAVLADAALDPAFKAEALTLPSEAYLAE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  637 LMKKMDVEALHTIRQFVKKALSNALVDDLKIQYEHHQLPL-YEYTPADIGKRKLKNICLAYLTESDDTQFRQVAYQQFKK 715
Cdd:pfam17432  81 QMDVVDPDAIHAAREALRRALAEALRDELLALYQALAATGpYSPDAAAAGRRALRNLALSYLAAAGDPEAADLAAAQFES 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  716 SDNMTDTVGALSALLNHDCKERHQALDEFYQQWKDQPLVVNKWLMLHASSTLPSTLEAVRKLTKHPAFDVKNPNNVYSLL 795
Cdd:pfam17432 161 ADNMTDRLAALAALVNSDLPEREEALADFYQRWKDDPLVMDKWFALQATSPRPDTLERVKALMQHPAFDLKNPNRVRALI 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  796 GTFG-ANAVCFHEGSGEGYRLIADYVLAIDPANPQVAARVLQPLTRWQMMDKKRQELMKAELNRIAKAERLSSDVYEIVT 874
Cdd:pfam17432 241 GAFAaANPVAFHAADGSGYRFLADQVLELDAINPQVAARLLTPLTRWRRYDPPRQALMRAALERIAATPGLSKDVFEIVS 320

                  ...
gi 692428049  875 KSL 877
Cdd:pfam17432 321 KAL 323
 
Name Accession Description Interval E-value
pepN_proteo TIGR02414
aminopeptidase N, Escherichia coli type; The M1 family of zinc metallopeptidases contains a ...
13-877 0e+00

aminopeptidase N, Escherichia coli type; The M1 family of zinc metallopeptidases contains a number of distinct, well-separated clades of proteins with aminopeptidase activity. Several are designated aminopeptidase N, EC 3.4.11.2, after the Escherichia coli enzyme, suggesting a similar activity profile (see SP|P04825 for a description of catalytic activity). This family consists of all aminopeptidases closely related to E. coli PepN and presumed to have similar (not identical) function. Nearly all are found in Proteobacteria, but members are found also in Cyanobacteria, plants, and apicomplexan parasites. This family differs greatly in sequence from the family of aminopeptidases typified by Streptomyces lividans PepN (TIGR02412), from the membrane bound aminopeptidase N family in animals, etc. [Protein fate, Degradation of proteins, peptides, and glycopeptides]


Pssm-ID: 274122 [Multi-domain]  Cd Length: 863  Bit Score: 1560.38  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   13 DYRPSDFLIDTVHLYFDLHEEETHVKTILNLQRNPEGNAtAPLALTGEAMTLKKVALDGQTLASSDYTLDASSLTIANVP 92
Cdd:TIGR02414   1 DYKPPPFLIEKTHLDFDLHEEETVVRARLTVRRNPDGNG-APLVLDGEELKLLSIAIDGKPLAAGDYQLDDETLTIASVP 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   93 NEFTLETEVVIKPQENTQLMGLYKSRGNFCTQCESHGFRRITYFLDRPDVMARYTTTIIADKNKYPFLLSNGNLIETKIL 172
Cdd:TIGR02414  80 ESFTLEIETEIHPEENTSLEGLYKSGGNFCTQCEAEGFRRITYFPDRPDVMSRYTVTITADKKKYPVLLSNGNKIASGEL 159
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  173 SDNRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVTQSGREIALRLYLEKGFKDQGPFSLAALKKAMRWDEKRFGREYDL 252
Cdd:TIGR02414 160 PDGRHWAEWEDPFPKPSYLFALVAGDLDVLEDTFTTKSGREVALRVYVEEGNKDKCDHAMESLKKAMKWDEEVFGLEYDL 239
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  253 DIYMIVAVSDFNMGAMENKGLNIFNTKYILANPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQITLKEGLTVFRE 332
Cdd:TIGR02414 240 DIFMIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFRD 319
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  333 QLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPRSYIEVNNFYTTTVYNKGSEVIRMVQTLLGEALFRKAMDLY 412
Cdd:TIGR02414 320 QEFSADMTSRAVKRIEDVRLLRAHQFPEDAGPMAHPVRPESYVEINNFYTATVYEKGAEVIRMLHTLLGEEGFRKGMDLY 399
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  413 FSRYDGQAVTTEDFIQAMEDASGKNLEQFKRWYDQAGTPVLDVNSEYNANDKTLTLTVKQSCPPTPGQSEKLPFHLPLTL 492
Cdd:TIGR02414 400 FSRHDGQAVTCEDFVAAMEDASGRDLNQFRRWYSQAGTPVLEVKENYDAAKKTYTLTVRQSTPPTPGQTEKKPLHIPIAV 479
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  493 GFVGPECQDMPTQLAGEkkaIPGTRVLEIKDAETEFKFVNVNHKPTLSLLRGFSAPVRLNYPYSDEELVWLFQCDSDPFA 572
Cdd:TIGR02414 480 GLLGPNGRKLMLSLDGE---RDTTRVLELTEAEQTFVFEGIAEKPVPSLLRGFSAPVNLEYPYSDEDLLLLLAHDSDPFN 556
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  573 RYEAGQIFAQRLIFKLIDDSYQGKPLKIDERFIDAHRKIIAGPHRDHWYEADLLQLPNINYLMQLMKKMDVEALHTIRQF 652
Cdd:TIGR02414 557 RWEAGQRLARRVILANIARAQGGEELPVDPAFIDALGKLLNDPHLDAAFKALLLALPSEAYLAELMENIDPDALHAAREF 636
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  653 VKKALSNALVDDLKIQYEHHQLPL-YEYTPADIGKRKLKNICLAYLTESDDTQFRQVAYQQFKKSDNMTDTVGALSALLN 731
Cdd:TIGR02414 637 LRAAIARQLADDLLRLYDALQENGpYSVDPAAAGRRALRNACLSYLSAADDAEIRNLALEQFKSADNMTDRLAALSALVH 716
                         730       740       750       760       770       780       790       800
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  732 HDCKERHQALDEFYQQWKDQPLVVNKWLMLHASSTLPSTLEAVRKLTKHPAFDVKNPNNVYSLLGTFG-ANAVCFHEGSG 810
Cdd:TIGR02414 717 FESDFRERALAAFYQKWKDDPLVMDKWFALQATSPRPDTLERVKALLQHPAFDLKNPNRVRALIGAFAnNNLVRFHDISG 796
                         810       820       830       840       850       860
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 692428049  811 EGYRLIADYVLAIDPANPQVAARVLQPLTRWQMMDKKRQELMKAELNRIAKAERLSSDVYEIVTKSL 877
Cdd:TIGR02414 797 SGYRFLADQIIAIDRFNPQVAARLLEPLTRWRKLDPKRQELMKAALERIAAEENLSKDVREVVSKAL 863
pepN PRK14015
aminopeptidase N; Provisional
1-877 0e+00

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 1555.10  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   1 MSNQKPRTVYLKDYRPSDFLIDTVHLYFDLHEEETHVKTILNLQRNPEGNATAPLALTGEAMTLKKVALDGQTLASSDYT 80
Cdd:PRK14015   1 MRTQQPQAIYLKDYRPPDYLIDTVDLDFDLDPDKTRVTARLQVRRNPDAAHSAPLVLDGEDLELLSLALDGQPLAPSAYE 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  81 LDASSLTIANVPNEFTLETEVVIKPQENTQLMGLYKSRGNFCTQCESHGFRRITYFLDRPDVMARYTTTIIADKNKYPFL 160
Cdd:PRK14015  81 LDEEGLTIENLPDRFTLEIETEIDPEANTALEGLYRSGGMFCTQCEAEGFRRITYFLDRPDVLARYTVRIEADKAKYPVL 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 161 LSNGNLIETKILSDNRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVTQSGREIALRLYLEKGFKDQGPFSLAALKKAMR 240
Cdd:PRK14015 161 LSNGNLVESGELPDGRHWATWEDPFPKPSYLFALVAGDLDVLEDTFTTRSGREVALEIYVEPGNLDKCDHAMDSLKKSMK 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 241 WDEKRFGREYDLDIYMIVAVSDFNMGAMENKGLNIFNTKYILANPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQ 320
Cdd:PRK14015 241 WDEERFGLEYDLDIFMIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQ 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 321 ITLKEGLTVFREQLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPRSYIEVNNFYTTTVYNKGSEVIRMVQTLL 400
Cdd:PRK14015 321 LSLKEGLTVFRDQEFSADLGSRAVKRIEDVRVLRAAQFAEDAGPMAHPVRPDSYIEINNFYTATVYEKGAEVIRMLHTLL 400
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 401 GEALFRKAMDLYFSRYDGQAVTTEDFIQAMEDASGKNLEQFKRWYDQAGTPVLDVNSEYNANDKTLTLTVKQSCPPTPGQ 480
Cdd:PRK14015 401 GEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASGRDLSQFRRWYSQAGTPRVTVSDEYDAAAGTYTLTLSQSTPPTPGQ 480
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 481 SEKLPFHLPLTLGFVGPECQDMPTQLAGEkkaiPGTRVLEIKDAETEFKFVNVNHKPTLSLLRGFSAPVRLNYPYSDEEL 560
Cdd:PRK14015 481 PEKQPLHIPVAIGLLDPDGKELPLQLEGE----PVERVLELTEAEQTFTFENVAERPVPSLLRGFSAPVKLEYDYSDEDL 556
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 561 VWLFQCDSDPFARYEAGQIFAQRLIFKLIDDsyQGKPLKIDERFIDAHRKIIAGPHRDHWYEADLLQLPNINYLMQLMKK 640
Cdd:PRK14015 557 LFLMAHDSDPFNRWEAGQRLATRLLLANVAR--HGQPLSLDEALIDAFRAVLLDESLDPAFAAELLTLPSEAELAEQMEV 634
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 641 MDVEALHTIRQFVKKALSNALVDDLKIQYEHHQLP-LYEYTPADIGKRKLKNICLAYLTESDDTQFRQVAYQQFKKSDNM 719
Cdd:PRK14015 635 IDPDAIHAAREALRRALATALKDELLALYEALQTDgPYSPDAEAAGRRALRNVCLSYLAAADDEEAAELAEAQFDQADNM 714
                        730       740       750       760       770       780       790       800
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 720 TDTVGALSALLNHDCKERHQALDEFYQQWKDQPLVVNKWLMLHASSTLPSTLEAVRKLTKHPAFDVKNPNNVYSLLGTF- 798
Cdd:PRK14015 715 TDRLAALSALVNADLPERDEALADFYDRWKDDPLVMDKWFALQATSPAPDTLERVRALMQHPAFDLKNPNRVRSLIGAFa 794
                        810       820       830       840       850       860       870
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 692428049 799 GANAVCFHEGSGEGYRLIADYVLAIDPANPQVAARVLQPLTRWQMMDKKRQELMKAELNRIAKAERLSSDVYEIVTKSL 877
Cdd:PRK14015 795 AANPAGFHAADGSGYRFLADQILALDKINPQVAARLATPLIRWRRYDPKRQALMRAALERIAALPNLSKDVREIVSKAL 873
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
13-445 0e+00

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 861.44  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  13 DYRPSDFLIDTVHLYFDLHEEETHVKTILNLQRNPEGNATAPLALTGEAMTLKKVALDGQTLASSDYTLDASSLTIANVP 92
Cdd:cd09600    1 DYKPPDFLIDHVDLDFDLDDDETIVTSRLRVRRNPDSGEGAPLVLDGEDLELLSVKIDGKPLSPSDYTLDEEGLTIKNVP 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  93 NEFTLETEVVIKPQENTQLMGLYKSRGNFCTQCESHGFRRITYFLDRPDVMARYTTTIIADKNKYPFLLSNGNLIETKIL 172
Cdd:cd09600   81 DRFVLEIEVRINPAANTSLEGLYKSGGILCTQCEAEGFRRITYFPDRPDVMSKFTVTIEADKEKYPVLLSNGNLIEEGEL 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 173 SDNRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVTQSGREIALRLYLEKGFKDQGPFSLAALKKAMRWDEKRFGREYDL 252
Cdd:cd09600  161 PNGRHFAVWEDPFPKPSYLFALVAGDLGSVEDTFTTKSGRKVKLRIYVEPGNEDKCHHAMESLKKAMKWDEERFGLEYDL 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 253 DIYMIVAVSDFNMGAMENKGLNIFNTKYILANPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQITLKEGLTVFRE 332
Cdd:cd09600  241 DLFNIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFRD 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 333 QLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPRSYIEVNNFYTTTVYNKGSEVIRMVQTLLGEALFRKAMDLY 412
Cdd:cd09600  321 QEFSADMNSRAVKRIEDVRRLRSAQFPEDAGPMAHPIRPDSYIEINNFYTVTVYEKGAEVIRMLHTLLGEEGFRKGMDLY 400
                        410       420       430
                 ....*....|....*....|....*....|...
gi 692428049 413 FSRYDGQAVTTEDFIQAMEDASGKNLEQFKRWY 445
Cdd:cd09600  401 FERHDGQAVTCEDFVAAMEDASGRDLSQFKRWY 433
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
6-590 0e+00

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 551.17  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   6 PRTVYLKDYRPSDFLIDTVHLYFDLHEEETHVKTILNLQRNPEGNATAPLALTGEAMTLKKVALDGQTLassDYTLDASS 85
Cdd:COG0308    2 KRLTRLEAYRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEAPLDSLVLDLKGLEVTSVTVDGKPL---DFTRDGER 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  86 LTIAN----VPNE-FTLETEVVIKPQEntQLMGLYKS------RGNFCTQCESHGFRRitYFL--DRPDVMARYTTTIIA 152
Cdd:COG0308   79 LTITLpkplAPGEtFTLEIEYSGKPSN--GGEGLYRSgdppdgPPYLYTQCEPEGARR--WFPcfDHPDDKATFTLTVTV 154
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 153 DKnkYPFLLSNGNLIETKILSDNRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVtqSGreIALRLYLEKGFKDQGPFSL 232
Cdd:COG0308  155 PA--GWVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFA--SG--VPLRVYVRPGLADKAKEAF 228
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 233 AALKKAMRWDEKRFGREYDLDIYMIVAVSDFNMGAMENKGLNIFNTKYIlaNPQSATDDNYVAIESVIGHEYFHNWSGNR 312
Cdd:COG0308  229 ESTKRMLDFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVL--ADETATDADYERRESVIAHELAHQWFGNL 306
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 313 VTCRDWFQITLKEGLTVFREQLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPRSYIEVNNFYTTTVYNKGSEV 392
Cdd:COG0308  307 VTCADWDDLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSYAFAEDAGPNAHPIRPDDYPEIENFFDGIVYEKGALV 386
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 393 IRMVQTLLGEALFRKAMDLYFSRYDGQAVTTEDFIQAMEDASGKNL-EQFKRWYDQAGTPVLDVNSEYNANDKTlTLTVK 471
Cdd:COG0308  387 LHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLsAFFDQWLYQAGLPTLEVEYEYDADGKV-TLTLR 465
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 472 QScpptpgQSEKLPFHLPLTLGFVGPEcqdmptqlagekkaIPGTRVLeIKDAETEFKfvnvnHKPTLSLLrgfsapVRL 551
Cdd:COG0308  466 QT------PPRPHPFHIPLEVGLLGGK--------------LTARTVL-LDGEQTELV-----AKPDPVLL------LRL 513
                        570       580       590
                 ....*....|....*....|....*....|....*....
gi 692428049 552 nypysDEELVWLFQCDSDPFARYEAGQIFAQRLIFKLID 590
Cdd:COG0308  514 -----DDELAFLLAHDSDPFNRWEALQALWRDGEADYLD 547
DUF3458_C pfam17432
Domain of unknown function (DUF3458_C) ARM repeats; This presumed domain is functionally ...
557-877 1.33e-144

Domain of unknown function (DUF3458_C) ARM repeats; This presumed domain is functionally uncharacterized. This domain is found in bacteria, archaea and eukaryotes.


Pssm-ID: 465424 [Multi-domain]  Cd Length: 324  Bit Score: 430.40  E-value: 1.33e-144
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  557 DEELVWLFQCDSDPFARYEAGQIFAQRLIFKLIDDSYQGKPLKIDERFIDAHRKIIAGPHRDHWYEADLLQLPNINYLMQ 636
Cdd:pfam17432   1 DEDLAFLLAHDSDPFNRWEAGQTLALRLLLALVAALQAGEPLALDAAFIDAFRAVLADAALDPAFKAEALTLPSEAYLAE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  637 LMKKMDVEALHTIRQFVKKALSNALVDDLKIQYEHHQLPL-YEYTPADIGKRKLKNICLAYLTESDDTQFRQVAYQQFKK 715
Cdd:pfam17432  81 QMDVVDPDAIHAAREALRRALAEALRDELLALYQALAATGpYSPDAAAAGRRALRNLALSYLAAAGDPEAADLAAAQFES 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  716 SDNMTDTVGALSALLNHDCKERHQALDEFYQQWKDQPLVVNKWLMLHASSTLPSTLEAVRKLTKHPAFDVKNPNNVYSLL 795
Cdd:pfam17432 161 ADNMTDRLAALAALVNSDLPEREEALADFYQRWKDDPLVMDKWFALQATSPRPDTLERVKALMQHPAFDLKNPNRVRALI 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  796 GTFG-ANAVCFHEGSGEGYRLIADYVLAIDPANPQVAARVLQPLTRWQMMDKKRQELMKAELNRIAKAERLSSDVYEIVT 874
Cdd:pfam17432 241 GAFAaANPVAFHAADGSGYRFLADQVLELDAINPQVAARLLTPLTRWRRYDPPRQALMRAALERIAATPGLSKDVFEIVS 320

                  ...
gi 692428049  875 KSL 877
Cdd:pfam17432 321 KAL 323
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
23-432 1.36e-116

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 361.38  E-value: 1.36e-116
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  23 TVHLYFDLHEEETHVKTILNLQrnpEGNATAPLALTGEAMTLKKVALDGQTLA-SSDYTLDASSLTIA---NVPNEFTLE 98
Cdd:cd09595    4 DLDLDVDFTTKTLNGTETLTVD---ASQVGRELVLDLVGLTIHSVSVNGAAVDfGEREHYDGEKLTIPgpkPPGQTFTVR 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  99 TEVVIKPQENTQL----MGLYKSRGNFCTQCESHGFRRITYFLDRPDVMARYTTTIIADKnkYPFLLSNGNLIETKILSD 174
Cdd:cd09595   81 ISFEAKPSKNLLGwlweQTAGKEKPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTPK--KDLLASNGALVGEETGAN 158
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 175 NRHWAHWEDPSKKPCYLFALVAGDFDLLEDTFVTQsgREIALRLYLEKGFKDQGPFSLAALKKAMRWDEKRFGREYDLDI 254
Cdd:cd09595  159 GRKTYRFEDTPPIPTYLVAVVVGDLEFKYVTVKSQ--PRVGLSVYSEPLQVDQAQYAFDATRAALAWFEDYFGGPYPLPK 236
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 255 YMIVAVSDFNMGAMENKGLNIFNTKYILanPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQITLKEGLTVFREQL 334
Cdd:cd09595  237 YDLLAVPDFNSGAMENPGLITFRTTYLL--RSKVTDTGARSIENVIAHELAHQWFGNLVTMRWWNDLWLNEGFAVYYENR 314
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 335 FTEDTT---SKGVARIGTVNILRNSQFPEDAGPMAHPIrpRSYIEVNNFYTTTVYNKGSEVIRMVQTLLGEALFRKAMDL 411
Cdd:cd09595  315 IMDATFgtsSRHLDQLSGSSDLNTEQLLEDSSPTSTPV--RSPADPDVAYDGVTYAKGALVLRMLEELVGEEAFDKGVQA 392
                        410       420
                 ....*....|....*....|.
gi 692428049 412 YFSRYDGQAVTTEDFIQAMED 432
Cdd:cd09595  393 YFNRHKFKNATTDDFIDALEE 413
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
230-444 4.24e-62

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 209.07  E-value: 4.24e-62
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  230 FSLAALKKAMRWDEKRFGREYDLDIYMIVAVSDFNMGAMENKGLNIFNTKYILANPQSATDDNYVAIESVIGHEYFHNWS 309
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  310 GNRVTCRDWFQITLKEGLTVFREQLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPI--RPRSYIEVNNFYTTTVYN 387
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPItqNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 692428049  388 KGSEVIRMVQTLLGEALFRKAMDLYFSRYDGQAVTTEDFIQAMEDASG-KNLEQF-KRW 444
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGpLDVDSFmDTW 219
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
62-445 9.02e-53

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 189.72  E-value: 9.02e-53
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  62 MTLKKVALDGQTLASsdYTLDASSLTIA-----NVPNEFTLETEVVIKPQENTQLMGLYKSRGN----FCTQCESHGFRr 132
Cdd:cd09603   43 LTVSSVTVDGVPAAF--FTHDGDKLVITlprplAAGETFTVTVRYSGKPRPAGYPPGDGGGWEEgddgVWTAGQPEGAS- 119
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 133 iTYF--LDRPDVMARYTTTIIADKNKYPflLSNGNLIETKILSDNRHWAHWEdpSKKPC--YLFALVAGDFDLLEDTfvt 208
Cdd:cd09603  120 -TWFpcNDHPDDKATYDITVTVPAGLTV--VSNGRLVSTTTNGGGTTTWHWK--MDYPIatYLVTLAVGRYAVVEDG--- 191
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 209 qSGREIALRLYLEKGFKDQGPFSLAALKKAMRWDEKRFGrEYDLDIYMIVAVSDFNmGAMENKGLNIFNTKYILANPQSa 288
Cdd:cd09603  192 -SGGGIPLRYYVPPGDAAKAKASFARTPEMLDFFEELFG-PYPFEKYGQVVVPDLG-GGMEHQTATTYGNNFLNGDRGS- 267
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 289 tddnyvaiESVIGHEYFHNWSGNRVTCRDWFQITLKEGLTVFREQLFTEDTTSKGVARiGTVNILRNSQFPEDAGPmahp 368
Cdd:cd09603  268 --------ERLIAHELAHQWFGDSVTCADWADIWLNEGFATYAEWLWSEHKGGADAYR-AYLAGQRQDYLNADPGP---- 334
                        330       340       350       360       370       380       390
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 692428049 369 irpRSYIEVNNFYTTTVYNKGSEVIRMVQTLLGEALFRKAMDLYFSRYDGQAVTTEDFIQAMEDASGKNLEQ-FKRWY 445
Cdd:cd09603  335 ---GRPPDPDDLFDRDVYQKGALVLHMLRNLLGDEAFFAALRAYLARYAHGNVTTEDFIAAAEEVSGRDLTWfFDQWL 409
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
108-438 2.38e-51

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 186.63  E-value: 2.38e-51
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 108 NTQLMGLYKSRGN---------FCTQCESHGFRRItyF--LDRPDVMARYTTTIIADKNKYPflLSNGNLIETKILSDNR 176
Cdd:cd09601   94 NDDLRGFYRSSYTdedgetrylAATQFEPTDARRA--FpcFDEPAFKATFDITITHPKGYTA--LSNMPPVESTELEDGW 169
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 177 HWAHWEdPSKK-PCYLFALVAGDFDLLEDTfvtqSGREIALRLYLEKGFKDQGPFSLAALKKAMRWDEKRFGREYDL--- 252
Cdd:cd09601  170 KTTTFE-TTPPmSTYLVAFVVGDFEYIEST----TKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPYPLpkl 244
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 253 DIymiVAVSDFNMGAMENKGLNIFNTKYILANPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQITLKEGL----- 327
Cdd:cd09601  245 DL---VAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFatyme 321
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 328 TVFREQLFTEDttskgvaRIGTVNILRNSQ--FPEDAGPMAHPIRP--RSYIEVNNFYTTTVYNKGSEVIRMVQTLLGEA 403
Cdd:cd09601  322 YLAVDKLFPEW-------NMWDQFVVDELQsaLELDSLASSHPIEVpvESPSEISEIFDAISYSKGASVLRMLENFLGEE 394
                        330       340       350
                 ....*....|....*....|....*....|....*
gi 692428049 404 LFRKAMDLYFSRYDGQAVTTEDFIQAMEDASGKNL 438
Cdd:cd09601  395 VFRKGLRKYLKKHAYGNATTDDLWEALQEASGESK 429
DUF3458 pfam11940
Domain of unknown function (DUF3458) Ig-like fold; This presumed domain is functionally ...
449-554 2.38e-35

Domain of unknown function (DUF3458) Ig-like fold; This presumed domain is functionally uncharacterized. This domain is found in bacteria, archaea and eukaryotes. The domain has an Ig-like fold. This domain is found associated with pfam01433.


Pssm-ID: 463405 [Multi-domain]  Cd Length: 95  Bit Score: 129.17  E-value: 2.38e-35
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  449 GTPVLDVNSEYNANDKTLTLTVKQSCPPTPGQSEKLPFHLPLTLGFVGPecqdmptqlAGEkkAIPGTRVLEIKDAETEF 528
Cdd:pfam11940   1 GTPRVTVSDSYDAAAGTYTLTLSQTTPPTPGQPEKQPLHIPIRIALLDP---------NGQ--ELALERVLELTEAEQTF 69
                          90       100
                  ....*....|....*....|....*.
gi 692428049  529 KFVNVNHKPTLSLLRGFSAPVRLNYP 554
Cdd:pfam11940  70 TFEGVAEKPVPSLLRGFSAPVKLEYD 95
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
25-444 9.70e-34

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 135.33  E-value: 9.70e-34
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  25 HLYFDL--HEEETHVKTILNLQRNPEGnatAPLALTGEAMTLKKVALDGQTLASSDYtlDASSLTIANVPNEFTLETEVV 102
Cdd:cd09602   19 DLDLDLteGAETFRGTVTIRFTLREPG---ASLFLDFRGGEVKSVTLNGRPLDPSAF--DGERITLPGLLKAGENTVVVE 93
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 103 IKPQENTQLMGLYKSR----GN--FCTQCESHGFRRItyF--LDRPDVMARYTTTIIADKN-KypfLLSNGNLIETKILS 173
Cdd:cd09602   94 FTAPYSSDGEGLHRFVdpadGEtyLYTLFEPDDARRV--FpcFDQPDLKATFTLTVTAPADwT---VISNGPETSTEEAG 168
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 174 DNRHWAHweDPSKK-PCYLFALVAGDFdlledTFVTQSGREIALRLYLEKGFKDQGpFSLAAL----KKAMRWDEKRFGR 248
Cdd:cd09602  169 GRKRWRF--AETPPlSTYLFAFVAGPY-----HRVEDEHDGIPLGLYCRESLAEYE-RDADEIfevtKQGLDFYEDYFGI 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 249 EYDLDIYMIVAVSDFNMGAMENKGLNIFNTKYILanPQSATDDNYVAIESVIGHEYFHNWSGNRVTCRDWFQITLKEGLT 328
Cdd:cd09602  241 PYPFGKYDQVFVPEFNFGAMENPGAVTFRESYLF--REEPTRAQRLRRANTILHEMAHMWFGDLVTMKWWDDLWLNESFA 318
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 329 VFREQLFTEDTTSKGVARIGTVNILRNSQFPEDAGPMAHPIRPrsyiEVNNfyTTTV--------YNKGSEVIRMVQTLL 400
Cdd:cd09602  319 DFMAAKALAEATPFTDAWLTFLLRRKPWAYRADQLPTTHPIAQ----DVPD--LEAAgsnfdgitYAKGASVLKQLVALV 392
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|....*
gi 692428049 401 GEALFRKAMDLYFSRYDGQAVTTEDFIQAMEDASGKNLEQFKR-W 444
Cdd:cd09602  393 GEEAFRAGLREYFKKHAYGNATLDDLIAALDEASGRDLSAWADaW 437
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
192-445 3.60e-24

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 106.59  E-value: 3.60e-24
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 192 FALVAGDfDLLEDTfVTQSGREIalRLYLEKGFKDQGPFSLAALKKAMRWDEKRFGrEYDLDIYMIVAvSDFNMGAMENK 271
Cdd:cd09604  204 FAWAASP-DFVVDA-ATVDGVTV--NVYYLPENAEAAERALEYAKDALEFFSEKFG-PYPYPELDVVQ-GPFGGGGMEYP 277
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 272 GLnIFNTKYILANPQSatddnyvaIESVIGHEYFHNWsgnrvtcrdWFQIT---------LKEGLTVFREQLFTEDTTSK 342
Cdd:cd09604  278 GL-VFIGSRLYDPKRS--------LEGVVVHEIAHQW---------FYGIVgnderrepwLDEGLATYAESLYLEEKYGK 339
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 343 GVARIGTVNILRNSQFPEDAGPMAHPIrprSYIEVNNFYTTTVYNKGSEVIRMVQTLLGEALFRKAMDLYFSRYDGQAVT 422
Cdd:cd09604  340 EAADELLGRRYYRAYARGPGGPINLPL---DTFPDGSYYSNAVYSKGALFLEELREELGDEAFDKALREYYRRYKFKHPT 416
                        250       260
                 ....*....|....*....|....
gi 692428049 423 TEDFIQAMEDASGKNLEQF-KRWY 445
Cdd:cd09604  417 PEDFFRTAEEVSGKDLDWFfRGWL 440
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
60-191 5.91e-18

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 82.78  E-value: 5.91e-18
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   60 EAMTLK-KVALDGQTLASSDY-TLDASSLTI-----------ANVPNEFTLETE----VVIKPQE--------------- 107
Cdd:pfam17900  14 KNFTFSgSVTITLQLNNATNViVLHASDLTIrsislsdevtsDGVPADFTEDQKdgekLTIVLPEtlnqtgpytleieys 93
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  108 ---NTQLMGLYKS--------RGNFCTQCESHGFRRITYFLDRPDVMARYTTTIIADKNKypFLLSNGNLIETKILSDNR 176
Cdd:pfam17900  94 gelNDSMTGFYRStytdngekKVLVTTQFEPTDARSAFPCFDEPSVKATFTISIIHPKDY--TALSNMPVIASEPLENGW 171
                         170
                  ....*....|....*
gi 692428049  177 HWAHWEDPSKKPCYL 191
Cdd:pfam17900 172 VITTFEQTPKMSTYL 186
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
123-432 1.93e-17

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 85.97  E-value: 1.93e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 123 TQCESHGFRRITYFLDRPDVMARYTTTIIADKNkYPFLLSnGNLIETKILSDNRHWaHWEDPSKKPCYLFALVAGDFDll 202
Cdd:cd09599  129 TQCQAIHARSLFPCQDTPSVKSTYSATVTVPKG-LTALMS-ALRTGEKEEAGTGTY-TFEQPVPIPSYLIAIAVGDLE-- 203
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 203 edtfvtqsGREIALR--LYLEKGFKDQGPFSLAALKKAMRWDEKRFGrEYDLDIY-MIVAVSDFNMGAMENKGLnIFNTK 279
Cdd:cd09599  204 --------SREIGPRsgVWAEPSVVDAAAEEFADTEKFLKAAEKLYG-PYVWGRYdLLVLPPSFPYGGMENPCL-TFATP 273
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 280 YILANPQSATDdnyvaiesVIGHEYFHNWSGNRVTCRDWFQITLKEGLTVF--R---EQLFTEDTTskGVARIGTVNILR 354
Cdd:cd09599  274 TLIAGDRSLVD--------VIAHEIAHSWSGNLVTNANWEHFWLNEGFTVYleRrilERLYGEEYR--QFEAILGWKDLQ 343
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049 355 NS--QFPEDAGPMAHPIrprsYIEVNN---FYTTTVYNKGSEVIRMVQTLLGEALFRKAMDLYFSRYDGQAVTTEDFIQA 429
Cdd:cd09599  344 ESikEFGEDPPYTLLVP----DLKGVDpddAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDF 419

                 ...
gi 692428049 430 MED 432
Cdd:cd09599  420 LLE 422
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
12-451 3.71e-16

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 82.90  E-value: 3.71e-16
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   12 KDYRPSDFlidTVHLYFDLHEEETHVKTILNLQRNPEGnaTAPLALTGEAMTLKKVALDGQtlaSSDYTLD------ASS 85
Cdd:TIGR02411   9 KDFRTSHT---DLNLSVDFTKRKLSGSVTFTLKSLTDN--LNKLVLDTSYLDIQKVTINGL---PADFAIGerkeplGSP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049   86 LTIaNVPNEFTLETEVVIKPQENT-------------QLMGlyKSRGNFCTQCESHGFRRITYFLDRPDVMARYTTTIia 152
Cdd:TIGR02411  81 LTI-SLPIATSKNDEFVLNISFSTtpkctalqwlnpeQTSG--KKHPYLFSQCQAIHARSLFPCQDTPSVKSTYTAEV-- 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  153 dKNKYPFLLSnGNLIETKILSDNRHWAHWEDPSkkPCYLFALVAGDFDlledtfvtqsGREIALR--LYLEKG--FKDQG 228
Cdd:TIGR02411 156 -ESPLPVLMS-GIRDGETSNDPGKYLFKQKVPI--PAYLIAIASGDLA----------SAPIGPRstVYSEPEqlEKCQY 221
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  229 PFSlAALKKAMRWDEKRFG----REYDLdiymIVAVSDFNMGAMENKGLNiFNTKYILANPQSATDdnyvaiesVIGHEY 304
Cdd:TIGR02411 222 EFE-NDTEKFIKTAEDLIFpyewGQYDL----LVLPPSFPYGGMENPNLT-FATPTLIAGDRSNVD--------VIAHEL 287
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  305 FHNWSGNRVTCRDWFQITLKEGLTVFREQ-----LFTEDTtsKGVARIGTVNILRNS--QFPEDAgPMAHPIRPRSYIEV 377
Cdd:TIGR02411 288 AHSWSGNLVTNCSWEHFWLNEGWTVYLERriigrLYGEKT--RHFSALIGWGDLQESvkTLGETP-EFTKLVVDLKDNDP 364
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 692428049  378 NNFYTTTVYNKGSEVIRMVQTLLG-EALFRKAMDLYFSRYDGQAVTTEDFIQAMED-------ASGKNLEQFKRWYDQAG 449
Cdd:TIGR02411 365 DDAFSSVPYEKGFNFLFYLEQLLGgPAEFDPFLRHYFKKFAYKSLDTYQFKDALYEyfkdkkkVDKLDAVDWETWLYSPG 444

                  ..
gi 692428049  450 TP 451
Cdd:TIGR02411 445 MP 446
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH